Join to View Full Profile
6363 France Ave SSte 610Edina, MN 55435
Phone+1 952-836-3645
Fax+1 952-836-3646
Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jocelin Huang is an oncologist in Edina, MN, currently practicing at M Health Cancer Care. She received her medical degree from University of Chicago Pritzker School of Medicine and has been in practice 11 years. She specializes in breast cancer, high risk breast cancer prevention, CLL, lymphoma, multiple myeloma, gastrointestinal cancer, and is experienced in hematologic oncology, breast cancer, myelodysplasia, and myelofibrosis.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2006
Certifications & Licensure
MN State Medical License 2007 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsReducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (W...Suzanne C Danhauer, Emily V Dressler, W Mark Brown, Chandylen L Nightingale, Gretchen A Brenes
Integrative Cancer Therapies. 2023-04-08 - 10 citationsInfection and Activation of B Cells by Theiler’s Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple SclerosisYoung Hee Jin, Charles X. Kim, Jocelin Huang, Byung S. Kim
Cells. 2020-07-27 - 31 citationsComparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147Jocelin Huang, Suresh G. Nair Md, Michelle R. Mahoney, Garth D. Nelson, Anthony F. Shields
Clinical Colorectal Cancer. 2014-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
